Cite
MLA Citation
Jesper Jørgensen et al.. “The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease.” Journal of market access & health policy, vol. 6, no. 1, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100066557231.0x000009